Poole Jonathan bought ACAD
March 3, 2026 · Form 4 insider transaction
Poole Jonathan bought 3,565 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 17 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,565
Price
$0.00
Total value
N/A
InsiderPoole Jonathan
RoleDirector
SecurityDirector Stock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 20, 2026
Shares owned after3,565
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders.